Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

De Rossi, Nicola; Scarpazza, Cristina; Filippini, Chiara; Cordioli, Cinzia; Rasia, Sarah; Mancinelli, Chiara Rosa; Rizzoni, Damiano; Romanelli, Giuseppe; Cossi, Stefania; Vettoretto, Nereo; Bove, Sergio; Manfredini, Silvano; Beindorf, Eva Andrea; Mosca, Carlo; Scipione, Vittorio; Flamminio, Gigliola; Albini Albini, Elena; Giansiracusa, Paola; Capra, Ruggero; on behalf of Montichiari COVID-19 Study Group

doi:https://doi.org/10.1016/j.eclinm.2020.100459

Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

dc.creator	De Rossi, Nicola
dc.creator	Scarpazza, Cristina
dc.creator	Filippini, Chiara
dc.creator	Cordioli, Cinzia
dc.creator	Rasia, Sarah
dc.creator	Mancinelli, Chiara Rosa
dc.creator	Rizzoni, Damiano
dc.creator	Romanelli, Giuseppe
dc.creator	Cossi, Stefania
dc.creator	Vettoretto, Nereo
dc.creator	Bove, Sergio
dc.creator	Manfredini, Silvano
dc.creator	Beindorf, Eva Andrea
dc.creator	Mosca, Carlo
dc.creator	Scipione, Vittorio
dc.creator	Flamminio, Gigliola
dc.creator	Albini Albini, Elena
dc.creator	Giansiracusa, Paola
dc.creator	Capra, Ruggero
dc.creator	on behalf of Montichiari COVID-19 Study Group
dc.date.accessioned	2020-09-21T13:39:05Z
dc.date.available	2020-09-21T13:39:05Z
dc.date.created	2020-08-01
dc.description.abstractenglish	Pneumonia with severe respiratory failure represents the principal cause of death in COVID-19, where hyper-inflammation plays an important role in lung damage. An effective treatment aiming at reducing the inflammation without preventing virus clearance is thus urgently needed. Tocilizumab, an anti-soluble IL-6 receptor monoclonal antibody, has been proposed for treatment of patients with COVID-19.	spa
dc.format.extent	9 páginas	spa
dc.format.mimetype	application/pdf	spa
dc.identifier.doi	https://doi.org/10.1016/j.eclinm.2020.100459	spa
dc.identifier.issn	2589-5370	spa
dc.identifier.other	https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30203-0/fulltext	spa
dc.identifier.uri	https://hdl.handle.net/20.500.12010/13493
dc.language.iso	eng	spa
dc.publisher	EClinicalMedicine	spa
dc.rights.accessrights	info:eu-repo/semantics/restrictedAccess	spa
dc.rights.local	Acceso restringido	spa
dc.source	reponame:Expeditio Repositorio Institucional UJTL	spa
dc.source	instname:Universidad de Bogotá Jorge Tadeo Lozano	spa
dc.subject	tocilizumab	spa
dc.subject	tocilizumab	spa
dc.subject	anti-soluble IL-6 receptor	spa
dc.subject.lemb	Síndrome respiratorio agudo grave	spa
dc.subject.lemb	COVID-19	spa
dc.subject.lemb	SARS-CoV-2	spa
dc.subject.lemb	Coronavirus	spa
dc.title	Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up	spa
dc.type.coar	http://purl.org/coar/resource_type/c_6501	spa
dc.type.hasversion	info:eu-repo/semantics/acceptedVersion	spa
dc.type.local	Artículo	spa

Archivos

Bloque original

Mostrando 1 - 1 de 1

Nombre:: Early use of low dose tocilizumab in patients with COVID-19 A retrospective cohort study with a complete follow-up.pdf
Tamaño:: 816.38 KB
Formato:: Adobe Portable Document Format
Descripción:: Documento Reservado

Descargar

Bloque de licencias

Mostrando 1 - 1 de 1

Nombre:: license.txt
Tamaño:: 2.87 KB
Formato:: Item-specific license agreed upon to submission
Descripción:

Descargar

Colecciones

Documentos científicos relacionados a la COVID-19